RANK aberrant activation has already been linked to basal-like cancers arising in BRCA1 mutation carriers, likely being an early event in preneoplasic BRCA1mut/+ breast tissue that favours oncogenesis [28]. This evidence concerns the gene BRCA1 and cancer.